Three of the four patients with BL samples that expressed ESR1 before start of therapy had clinically diagnosed HR+ breast cancer but in one patient (#8) the disease had changed phenotype from primary tumor (HR+) to metastasis (TNBC, Table 2). The gene discussed is ESR1; the disease is Burkitt lymphoma.